Compare IDEXX Laboratories, Inc. (IDXX) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs ProShares Ultra Gold ETF — how do they compare? IDEXX Laboratories, Inc. trades at $556.84 (market cap $44.48B), while ProShares Ultra Gold ETF trades at $44.62. Which is the better fit depends on your goals.
| IDXX | UGL | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $766.68 | $85.62 |
52-Week Low | $520.87 | $33.59 |
Enterprise Value | $45.38B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
UGL, the ProShares Ultra Gold ETF, trades at $43.39, down 0.41% amid bearish technical signals. The leveraged ETF faces pressure from higher interest rate expectations and a stronger dollar, with gold struggling to hold the $4,000 support level. Recent news highlights mixed sentiment, with Wall Street bearish on near-term gold prospects but long-term structural drivers like central bank buying remaining intact.
Outlook remains cautious as UGL's performance hinges on gold price volatility and Fed policy. Risks include leveraged decay and macroeconomic shifts, while opportunities exist if gold resumes its bull trend. Investors should weigh the ETF's high sensitivity to daily gold moves against current bearish technical and sentiment indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
